About usOur ApproachOur PipelinePatientsInvestorsCareers

You are leaving Spyre

If you would like to proceed, click the link to continue.
https://twitter.com/

Go back
Continue
Spyre is not responsible for content on external websites.
Please review their Privacy Policy.
Back to People
Cameron Turtle

Cameron Turtle

Chief Executive Officer

Cameron Turtle, D.Phil., is Chief Executive Officer. He is an experienced leader in building, financing, and shaping biopharma organizations from preclinical development to late-stage clinical trials and commercialization. Previously, he served as Venture Partner at Foresite Labs, Chief Strategy Officer of BridgeBio Pharma, Chief Business Officer of Eidos Therapeutics, and as a consultant at McKinsey & Company. Dr. Turtle also serves on the board of directors of Damora Therapeutics, Inc. (Nasdaq: DMRA) and formerly served on the board of directors of Oruka Therapeutics, Inc.(Nasdaq: ORKA). Dr. Turtle received his B.S. with honors in bioengineering from the University of Washington and his D.Phil. in cardiovascular medicine from the University of Oxford, St. John’s College. He is the recipient of several awards, including a Rhodes Scholarship, a Goldwater Scholarship, Forbes 30 Under 30, and San Francisco Business Times 40 Under 40.

‍